Loading...
XBKK
JCT
Market cap32mUSD
Nov 12, Last price  
81.25THB
Name

Jack Chia Industries Thailand PCL

Chart & Performance

D1W1MN
XBKK:JCT chart
P/E
9.46
P/S
1.26
EPS
8.59
Div Yield, %
5.23%
Shrs. gr., 5y
Rev. gr., 5y
1.96%
Revenues
872m
+5.68%
380,080,506473,082,229557,628,391549,401,197573,000,918594,966,477728,632,101744,705,930832,096,644830,194,342824,398,859820,496,207821,926,844884,966,872791,349,280698,784,004731,951,847885,750,294825,322,588872,188,665
Net income
116m
+17.55%
34,187,24273,999,58184,280,53899,580,47767,930,56583,382,73593,214,50094,633,525122,889,24197,382,11775,132,29488,745,07889,676,83590,706,80567,317,71165,502,91688,420,68695,128,70298,670,395115,989,883
CFO
148m
+58.92%
22,294,48593,550,20569,868,471118,181,20523,837,15465,929,89050,757,293108,786,734119,905,761108,959,861130,881,772119,889,03899,707,86189,190,270123,477,044108,267,09445,071,46666,388,67093,090,362147,943,135
Dividend
Mar 12, 20254.5 THB/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jack Chia Industries (Thailand) Public Company Limited, together with its subsidiaries, manufactures and distributes pharmaceutical and cosmetic products in Thailand. The company operates in two segments, Pharmaceutical Products and Other Consumer Products. It offers medical supplies, wound care equipment, sports tapes, and hygiene products under the Tigerplast and Tensoplast brands; cosmetic products comprising perfume, soap, shower gel, powders, etc. under the Tabu brand; eucalyptus health products and household items under the Kangaroo brand; hot compress products under the Thermaplast brand; candy products under the Jason brand; multipurpose lighter fluid products under the Ronsonol brand; and agricultural tape products and cockfighting tapes under the Golden Lion brand. The company was founded in 1966 and is based in Bangkok, Thailand.
IPO date
Sep 24, 1990
Employees
Domiciled in
TH
Incorporated in
TH

Valuation

Title
THB in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT